These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2970981)

  • 21. Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    Luippold G; Bedenik J; Voigt A; Grempler R
    PLoS One; 2016; 11(6):e0156346. PubMed ID: 27253523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
    Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
    Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats.
    Reckelhoff JF; Tygart VL; Mitias MM; Walcott JL
    Diabetes; 1993 Oct; 42(10):1425-32. PubMed ID: 8397128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Tomiyoshi Y; Sakemi T; Aoki S; Miyazono M
    Nephron; 2002 Dec; 92(4):860-7. PubMed ID: 12399633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions.
    Rasch R
    Diabetologia; 1979 Oct; 17(4):243-8. PubMed ID: 499683
    [No Abstract]   [Full Text] [Related]  

  • 27. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN; Heinrich A; Brilloff S; Jarzebska N; Martens-Lobenhoffer J; Bode-Böger SM; Todorov VT; Hugo CPM; Weiss N; Hohenstein B
    Atheroscler Suppl; 2017 Nov; 30():319-325. PubMed ID: 29096857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats.
    Stackhouse S; Miller PL; Park SK; Meyer TW
    Diabetes; 1990 Aug; 39(8):989-95. PubMed ID: 2373266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of xiaoke granule on blood glucose, urinary protein and glomerular morphology in rats with diabetic nephropathy].
    Ji XM; Wang Q; Qi F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jun; 24(6):534-7. PubMed ID: 15250209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI; Safirstein RL; McEvoy RC; Hsueh W
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence of changes in KK mouse nephropathy.
    Wehner H
    Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of continuous subcutaneous insulin infusion on renal morphology in experimental diabetes. I. Blood glucose levels, body size, kidney weight and glomerulotubular morphometry.
    Mayhew TM; Sharma AK; McCallum KN
    J Pathol; 1987 Feb; 151(2):147-55. PubMed ID: 3572611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of bromhexine on experimentally induced diabetic nephropathy.
    Luscombe M; Poulding JM; Amer B; Clamp JR; Hartog M; Shelley JH; Tribe CR
    Br J Exp Pathol; 1983 Aug; 64(4):462-5. PubMed ID: 6615713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy.
    Yang G; Cheng Q; Liu S; Zhao J
    PLoS One; 2015; 10(9):e0137245. PubMed ID: 26340671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation.
    Steffes MW; Vernier RL; Brown DM; Basgen JM; Mauer SM
    Diabetologia; 1982 Oct; 23(4):347-53. PubMed ID: 6814977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
    Nicholas SB; Mauer M; Basgen JM; Aguiniga E; Chon Y
    Am J Nephrol; 2004; 24(5):549-56. PubMed ID: 15539791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation.
    Mauer SM; Steffes MW; Sutherland DE; Najarian-S ; Michael AF; Brown DM
    Diabetes; 1975 Mar; 24(3):280-5. PubMed ID: 123209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.